Comment from Anonymous

Situation The FDA’s Center for Veterinary Medicine (CVM) provides guidance to pet food manufacturers regarding the use and substantiation of Relative Supersaturation (RSS) claims in adult maintenance cat foods. Relative Supersaturation is a measure used to estimate the likelihood of urinary crystal or urolith formation in cats. Although RSS methodology has long been utilized in human medicine, the FDA CVM recommends that pet food manufacturers substantiate RSS-related claims through efficacy trials before including such statements on product labeling. Background In 2018, urolith analysis revealed that 46.2% of uroliths were calcium oxalate-containing, 47.1% were struvite-containing, 9.2% were urate-containing, and 7.5% were apatite-containing (Kopecny et al., 2021). Relative Supersaturation has been validated in both human medicine and companion animal species and provides a standardized method for assessing the risk of urolith formation (Robertson et al., 2002). Health claims made on animal maintenance diets, particularly those incorporated into therapeutic management plans, should be supported by scientific studies to verify their safety and efficacy. Standardized research protocols in veterinary nutrition promote consistent animal welfare standards and enable reproducibility of results, strengthening the reliability of findings. Assessment In the absence of clear guidance, pet food manufacturers would lack a standardized approach for evaluating RSS-related claims. This could lead to inconsistencies across products and uncertainty for consumers regarding the accuracy and validity of RSS statements on pet food labels. The proposed guidance establishes standardized methods for RSS testing and safety evaluation in veterinary diets. By following these methods, manufacturers can generate consistent, comparable data across the industry. This consistency reassures consumers that RSS-formulated diets have been evaluated for both safety and effectiveness. If guidance evolves into regulatory requirements, manufacturers would be obligated to demonstrate conclusively that their diets achieve urinary RSS levels that reduce the risk of urolith formation while remaining safe for long-term pet consumption. Such requirements would further enhance consumer confidence and transparency. Recommendation FDA CVM continues providing guidance on the proper testing of safety and efficacy for RSS-based urinary diets intended for pet consumption. Consideration should be given to transitioning these guidelines into formal requirements in the future to ensure continued consumer trust, scientific integrity, and accurate labeling practices within the pet food industry.